AkandaSTU:Y232 21 OCF Margin % is -2,465.91% as of Dec. 2025. GuruFocus rates STU:Y232 with a GF Score™ of 21/100. The stock has 9 warning signs investors should review. Among 959 Drug Manufacturers companies, Akanda ranks worse than 98.02% on this metric.
The historical rank and industry rank for Akanda's OCF Margin % or its related term are showing as below:
STU:Y232'
s OCF Margin % Range Over the Past 10 Years
Min: -67600 Med: -2608.14 Max: -354.01
Current: -2614.09
During the past 7 years, the highest OCF Margin % of Akanda was -354.01%. The lowest was -67600.00%. And the median was -2608.14%.
STU:Y232's OCF Margin % is ranked worse than 98.02% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.94
vs STU:Y232: -2614.09
Akanda OCF Margin % Related Terms
Akanda OCF Margin % Historical Data
* Premium members only.
The historical data trend for Akanda's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:Y232 vs BFRI, BIOE, CABR: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Akanda's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Akanda OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Akanda's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Akanda's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akanda (STU:Y232) has a OCF Margin % of -2,465.91% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Akanda and its competitors. According to the industry distribution chart, Akanda ranks #940 out of 959 companies in the Drug Manufacturers industry, placing it in the top 98%.
Is Akanda's OCF Margin % too high?
Akanda's current OCF Margin % is -2,465.91%. Based on the distribution chart, Akanda ranks #940 out of 959 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Akanda has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Akanda's OCF Margin % compare to BFRI and BIOE?
According to the Drug Manufacturers industry distribution chart, Akanda ranks #940 out of 959 companies for OCF Margin %. This places Akanda in the lower half of its industry. The industry median OCF Margin % is 9.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Akanda and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Akanda's current OCF Margin % is -2,465.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akanda stock overvalued right now?
Akanda (STU:Y232) has a current OCF Margin % of -2,465.91%. The current OCF Margin % is -2,465.91%. Akanda's overall GF Score™ is 21/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Akanda (STU:Y232), the current OCF Margin % is -2,465.91% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company is a medical cannabis & hemp and wellness platform company seeking to help people lives through improved access to high-quality and affordable products. The Company is also in the business of leasing fiber optic networks and telecommunication towers, through its subsidiary. The company has four reportable segments: Infrastructure, Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Infrastructure segment, which relates to the leasing and/or rental of fiber optic networks and telecommunication towers at First Towers in Mexico.
21GF Score
Get the complete analysis for STU:Y232
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:Y232 has been successfully added to your 
